Response Pharmaceuticals has announced positive top-line results from its double-blind, placebo-controlled Phase 2 clinical trial...

Adolescents who undergo bariatric surgery face a higher risk of weight regain if they have elevated blood levels of per- and...

Welcome to our regular round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Patients waiting for operations could safely use glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to lose excess weight and reduce...

Salk Institute scientists are looking for a new treatment strategy in microproteins, an understudied class of molecules found throughout...

OIKOS has introduced OIKOS FUSION, which according to the company is the first of its kind, nutrient-dense cultured dairy drink developed...

Obesity Canada, in collaboration with the Canadian Association for Bariatric Physicians and Surgeons, has developed the Canadian Adult...

Boston Scientific has introduced its Endura Weight Loss Solutions representing a range of weight loss procedures, including endoscopic...

Eli Lilly and Company has announced positive topline results from the Phase 3 ATTAIN-1 trial, evaluating orforglipron, an investigational...

Endoscopic sleeve gastroplasty (ESG) may be an effective alternative therapy in the treatment of patients with metabolic...

Ascletis Pharma has completed enrolment in its US 13-week Phase IIa study evaluating ASC30, a small molecule oral GLP-1 receptor (GLP-1R)...

Vivani Medical has revealed that results from the LIBERATE-1 clinical study, a Phase 1 study of the exenatide GLP-1 implant NPM-115...